Knygos.lt klubas Knygos.lt nariams
435,95 €
-35%
Įprastai
670,69 €
Nonclinical Evaluation Studies of Cellular and Gene Therapy Products
Nonclinical Evaluation Studies of Cellular and Gene Therapy Products
Knygos.lt klubas Knygos.lt nariams
435,95 €
-35%
Įprastai
670,69 €
  • Planuojame turėti už 43 d.
Nonclinical Evaluation Studies of Cellular and Gene Therapy Products: Strategies, Models, and Regulatory Frameworks systematically explores the nonclinical evaluation of Cell and Gene Therapies (CGT) products, emphasizing risk mitigation and innovation. The book provides comprehensive coverage, including 20+ chapters spanning preclinical toxicology, pharmacokinetics, and novel evaluation models. It is the first book to integrate organ-on-chip models into CGT evaluation, reflecting FDA/NMPA mode…
  • Leidėjas:
  • Metai: 2026
  • Puslapiai: 650
  • ISBN-10: 0443486123
  • ISBN-13: 9780443486128
  • Kalba: Anglų

Nonclinical Evaluation Studies of Cellular and Gene Therapy Products (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

Nonclinical Evaluation Studies of Cellular and Gene Therapy Products: Strategies, Models, and Regulatory Frameworks systematically explores the nonclinical evaluation of Cell and Gene Therapies (CGT) products, emphasizing risk mitigation and innovation. The book provides comprehensive coverage, including 20+ chapters spanning preclinical toxicology, pharmacokinetics, and novel evaluation models. It is the first book to integrate organ-on-chip models into CGT evaluation, reflecting FDA/NMPA modernization initiatives. It includes practical guidance on addressing CRISPR off-target effects, immunogenicity, and long-term carcinogenicity risks.

Knygos.lt klubas
Knygos.lt nariams
435,95 €
-35%
Įprastai
670,69 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 4,36 Knygų Eurų!?
Planuojame turėti už 43 d.
Įsigykite dovanų kuponą
Daugiau
  • Leidėjas:
  • Metai: 2026
  • Puslapiai: 650
  • ISBN-10: 0443486123
  • ISBN-13: 9780443486128
  • Kalba: Anglų

Nonclinical Evaluation Studies of Cellular and Gene Therapy Products: Strategies, Models, and Regulatory Frameworks systematically explores the nonclinical evaluation of Cell and Gene Therapies (CGT) products, emphasizing risk mitigation and innovation. The book provides comprehensive coverage, including 20+ chapters spanning preclinical toxicology, pharmacokinetics, and novel evaluation models. It is the first book to integrate organ-on-chip models into CGT evaluation, reflecting FDA/NMPA modernization initiatives. It includes practical guidance on addressing CRISPR off-target effects, immunogenicity, and long-term carcinogenicity risks.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)